Valsartan Tablets Recalled for Potential Labeling Mixup with Other Drugs
Aidapak Services is recalling Valsartan 160 mg tablets because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling mixup. Per the rubric, minor labeling errors and voluntary precautionary recalls without reported injuries fall under the Moderate severity category.
Plain-English summary
Aidapak Services, LLC is recalling Valsartan, Tablet, 160 mg (NDC 00078035934) due to a labeling error. The source text indicates that the Valsartan tablets may have potentially been mislabeled as one of three other specific drugs: Progesterone, Capsule, 100 mg; CapsuleTOPRIL, Tablet, 6.25 mg; or Mycophenolate Mofetil, Tablet, 500 mg.
The recalled product consists of 1,260 tablets. The repacked drugs were distributed in Arizona, California, Oregon, and Washington. The source text lists specific pedigree codes and expiration dates for the affected Valsartan lots, ranging from May 16, 2014, to June 25, 2014.
Consumers and healthcare providers should check their inventory for Valsartan 160 mg tablets with the specific pedigree codes listed in the recall notice. If the product matches the description, it should be stopped from use and returned to the distributor or pharmacy for proper handling.
The recalled product
- Product
- VALSARTAN, Tablet, 160 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00078035934.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 1,260
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (19)
- VALSARTAN
- Tablet
- 160 mg has the following codes: Pedigree: AD39858_1
- EXP: 5/16/2014
- Pedigree: AD46312_7
- Pedigree: AD49414_7
- EXP: 5/17/2014
- Pedigree: W002767
- EXP: 6/6/2014
- Pedigree: W003534
- EXP: 6/21/2014
- Pedigree: W003639
- EXP: 6/25/2014
- Pedigree: W002851
- EXP: 6/7/2014
- Pedigree: AD62995_1
- EXP: 5/28/2014
- Pedigree: W002964
- EXP: 6/11/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02